Neurogene (NGNE) Other Working Capital Changes (2013 - 2026)

Neurogene (NGNE) has 7 years of Other Working Capital Changes data on file, last reported at -$755000.0 in Q1 2026.

• Quarterly Other Working Capital Changes fell 6.94% year-over-year to -$755000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 million (down 11.12% YoY) and the FY2025 annual result came in at -$2.9 million, down 13.41% from the prior year.
• Other Working Capital Changes retreated to -$755000.0 in Q1 2026, from -$740000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.4 million in Q1 2024 to a low of -$1.4 million in Q2 2024.
• A 5-year average of -$60117.6 and a median of -$33000.0 in 2025 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes soared 195.77% — and 2024, when it sank 284.71%.
• Tracing NGNE's Other Working Capital Changes over 5 years: stood at $249000.0 in 2022, then plunged by 171.08% to -$177000.0 in 2023, then plunged by 283.05% to -$678000.0 in 2024, then dropped by 9.14% to -$740000.0 in 2025, then slipped by 2.03% to -$755000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$755000.0 (Q1 2026), -$740000.0 (Q4 2025), and -$745000.0 (Q3 2025), per Business Quant data.